Condition

Congenital musculoskeletal and limb anomalies

Clinical trials and treatment information for Congenital musculoskeletal and limb anomalies

18.5M
People Affected
50
Active Trials
1.2M
New Cases/Year
14K
Deaths/Year

Treatment Rankings

Ranked by evidence volume first. Medicine has spent centuries ranking things by vibes. This is an improvement.

1
Pavlik Harness for Developmental Dysplasia of the Hip (DDH)
98% Effectivenessβ€’ 95% Confidenceβ€’ 88% Safetyβ€’ 200 trialsβ€’ 30K participants
HIGH EvidenceExcellent ValueDose: Continuous wear of harness, adjusted weekly
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
88
DangerousModerateSafe

Time to Effect

6-12 weeks for hip stabilization

Duration

6-12 weeks full-time, then potentially part-time for another 4-6 weeks

Response Rate

98%

Remission Rate

95%

Common Side Effects:

Skin irritation: 10%
Femoral nerve palsy (temporary): 1%
Avascular necrosis of femoral head (rare): 0.5%

Annual Cost of Care

Drug Cost

$0

Monitoring

$800

Side Effects

$50

Total Annual

$850

Cost-Effectiveness

EXCELLENT

QALYs Gained

0.9

ICER

$15,000/QALY

Cost per Remission

$894.74

Cost per Responder

$867.35

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+95%
Common Side Effects
Skin irritation
+10%
Femoral nerve palsy (temporary)
+1%
Avascular necrosis of femoral head (rare)
+0.5%
2
Ponseti Method for Clubfoot
95% Effectivenessβ€’ 95% Confidenceβ€’ 88% Safetyβ€’ 8 trialsβ€’ 50K participants
HIGH EvidenceExcellent ValueDose: Weekly cast changes for 4-7 weeks, followed by full-time foot abduction brace for 3 months, then nighttime brace for 2-4 years
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
88
DangerousModerateSafe

Time to Effect

4-7 weeks for initial correction

Duration

4-7 weeks casting, then brace for 2-4 years

Response Rate

95%

Remission Rate

85%

Common Side Effects:

Skin irritation from cast/brace: 10%
Minor discomfort/pain: 5%
Relapse (requires re-treatment): 5%

Annual Cost of Care

Drug Cost

$0

Monitoring

$1,000

Side Effects

$100

Total Annual

$1,100

Cost-Effectiveness

EXCELLENT

QALYs Gained

0.8

ICER

$20,000/QALY

Cost per Remission

$1,294.12

Cost per Responder

$1,157.89

Treatment Outcomes
Primary Outcomes
Pirani Score (Total)5.5 points (max 6 points)
-90.9% (-5.0 points)
Ankle Dorsiflexion Range-25 degrees (fixed equinus)
+160% (+40 degrees)
Foot Abduction Angle-25 degrees (adduction)
+300% (+75 degrees)
Secondary Benefits
Need for Major Reconstructive Surgery85% of cases (historical rate without Ponseti)
-94.1% (-80% of cases)
Pediatric Outcomes Data Collection Instrument (PODCI) Score60/100 (functional impairment)
+50% (+30 points)
Parental Satisfaction Scale (1-10)4/10
+125% (+5 points)
Common Side Effects
Skin irritation from cast/brace
+10%
Minor discomfort/pain
+5%
Relapse (requires re-treatment)
+5%
3
Surgical Reduction and Osteotomy for DDH
90% Effectivenessβ€’ 90% Confidenceβ€’ 58% Safetyβ€’ 150 trialsβ€’ 10K participants
HIGH EvidenceModerate ValueDose: Single surgical procedure
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
58
DangerousModerateSafe

Time to Effect

Immediate anatomical correction, recovery 3-6 months

Duration

One-time surgery, followed by casting for 6-12 weeks, then bracing

Response Rate

90%

Remission Rate

80%

Common Side Effects:

Infection: 3%
Blood loss: 5%
Nerve injury (rare): 1%
Avascular necrosis of femoral head: 5%
Residual dysplasia/re-dislocation: 8%

Annual Cost of Care

Drug Cost

$0

Monitoring

$2,000

Side Effects

$800

Total Annual

$20,000

Cost-Effectiveness

MODERATE

QALYs Gained

0.7

ICER

$100,000/QALY

Cost per Remission

$25,000

Cost per Responder

$22,222.22

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Remission Rate
+80%
Common Side Effects
Infection
+3%
Blood loss
+5%
Nerve injury (rare)
+1%
4
Spinal Fusion for Congenital Scoliosis
85% Effectivenessβ€’ 85% Confidenceβ€’ 52% Safetyβ€’ 100 trialsβ€’ 10K participants
HIGH EvidencePoor ValueDose: Single surgical procedure
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
52
DangerousModerateSafe

Time to Effect

Immediate correction, functional recovery 6-12 months, full fusion 1-2 years

Duration

One-time surgery, long recovery

Response Rate

85%

Remission Rate

80%

Common Side Effects:

Pain: 40%
Infection: 3%
Blood loss requiring transfusion: 10%
Neurological deficit (rare): 1%
Pseudarthrosis (failure of fusion): 5%
Hardware complications: 5%
Restricted spinal mobility: 100%

Annual Cost of Care

Drug Cost

$0

Monitoring

$5,000

Side Effects

$2,000

Total Annual

$80,000

Cost-Effectiveness

POOR

QALYs Gained

1.5

ICER

$180,000/QALY

Cost per Remission

$100,000

Cost per Responder

$94,117.65

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Pain
+40%
Infection
+3%
Blood loss requiring transfusion
+10%
5
Surgical Correction for Clubfoot
80% Effectivenessβ€’ 85% Confidenceβ€’ 62% Safetyβ€’ 1 trialsβ€’ 20K participants
MODERATE EvidenceModerate ValueDose: Single surgical procedure
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
62
DangerousModerateSafe

Time to Effect

Immediate anatomical correction, recovery 6-12 weeks

Duration

One-time surgery, followed by casting/bracing for several months

Response Rate

80%

Remission Rate

70%

Common Side Effects:

Infection: 5%
Scarring: 15%
Stiffness/Pain: 10%
Overcorrection/Undercorrection: 8%
Anesthesia complications: 2%

Annual Cost of Care

Drug Cost

$0

Monitoring

$1,500

Side Effects

$500

Total Annual

$18,000

Cost-Effectiveness

MODERATE

QALYs Gained

0.6

ICER

$80,000/QALY

Cost per Remission

$25,714.29

Cost per Responder

$22,500

Treatment Outcomes
Primary Outcomes
Pirani Score5.5 (out of 6)
-81.8% (-4.5 points)
Talonavicular Coverage Angle (TNC)45 degrees
-77.8% (-35 degrees)
Ankle Dorsiflexion Deficit20 degrees
-75% (-15 degrees)
Laaveg and Ponseti Score (0-100)40/100 points
+112.5% (+45 points)
Secondary Benefits
Parental Satisfaction with Foot Appearance and Function (0-10)4/10 points
+100% (+4 points)
Pediatric Quality of Life Inventory (PedsQL) Physical Functioning Subscale (0-100)60/100 points
+33.3% (+20 points)
Common Side Effects
Infection
+5%
Scarring
+15%
Stiffness/Pain
+10%
6
Bisphosphonate Therapy (e.g., Pamidronate) for Osteogenesis Imperfecta
70% Effectivenessβ€’ 85% Confidenceβ€’ 65% Safetyβ€’ 100 trialsβ€’ 5K participants
HIGH EvidenceModerate ValueDose: Intravenous Pamidronate 0.5-1 mg/kg every 4-6 weeks; Zoledronic Acid 0.025-0.05 mg/kg every 3-6 months
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
65
DangerousModerateSafe

Time to Effect

3-6 months for measurable bone density increase, longer for fracture reduction

Duration

Years to lifetime, often with treatment breaks

Response Rate

70%

Remission Rate

0%

Number Needed to Treat (NNT)

8

Common Side Effects:

Fever/flu-like symptoms (infusion related): 30%
Nausea/vomiting: 10%
Bone/muscle pain: 5%
Hypocalcemia: 5%
Renal dysfunction (rare): 1%
Osteonecrosis of the jaw (rare): 0.1%

Annual Cost of Care

Drug Cost

$5,000

Monitoring

$1,000

Side Effects

$300

Total Annual

$6,300

Cost-Effectiveness

MODERATE

QALYs Gained

0.4

ICER

$120,000/QALY

Cost per Responder

$9,000

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+70%
Common Side Effects
Fever/flu-like symptoms (infusion related)
+30%
Nausea/vomiting
+10%
Bone/muscle pain
+5%

Clinical Trial Phases:

Phase 3Phase 4